Furthermore, CCB use was associated with reduced risk of TMPRSS2:ERG positive (T2E+), which represents fusion of the androgen-regulated gene, TMPRSS2 and the oncogene ERG, but CCB use was not associated with T2E- PCa. The gene discussed is TMPRSS2; the disease is posterior cortical atrophy.